GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » EV-to-EBITDA

Greenbrook TMS (Greenbrook TMS) EV-to-EBITDA : -3.59 (As of May. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Greenbrook TMS's enterprise value is $131.46 Mil. Greenbrook TMS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-36.66 Mil. Therefore, Greenbrook TMS's EV-to-EBITDA for today is -3.59.

The historical rank and industry rank for Greenbrook TMS's EV-to-EBITDA or its related term are showing as below:

GBNHF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -30.03   Med: -7.26   Max: -0.13
Current: -4.45

During the past 9 years, the highest EV-to-EBITDA of Greenbrook TMS was -0.13. The lowest was -30.03. And the median was -7.26.

GBNHF's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 12.935 vs GBNHF: -4.45

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-20), Greenbrook TMS's stock price is $0.0911. Greenbrook TMS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.270. Therefore, Greenbrook TMS's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Greenbrook TMS EV-to-EBITDA Historical Data

The historical data trend for Greenbrook TMS's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS EV-to-EBITDA Chart

Greenbrook TMS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -9.83 -7.35 -7.91 -2.08 -3.95

Greenbrook TMS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.51 -0.35 -0.15 -3.95 -

Competitive Comparison of Greenbrook TMS's EV-to-EBITDA

For the Medical Care Facilities subindustry, Greenbrook TMS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenbrook TMS's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Greenbrook TMS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Greenbrook TMS's EV-to-EBITDA falls into.



Greenbrook TMS EV-to-EBITDA Calculation

Greenbrook TMS's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=131.459/-36.659
=-3.59

Greenbrook TMS's current Enterprise Value is $131.46 Mil.
Greenbrook TMS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenbrook TMS  (OTCPK:GBNHF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Greenbrook TMS's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0911/-1.270
=At Loss

Greenbrook TMS's share price for today is $0.0911.
Greenbrook TMS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.270.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Greenbrook TMS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenbrook TMS (Greenbrook TMS) Business Description

Traded in Other Exchanges
N/A
Address
890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Greenbrook TMS (Greenbrook TMS) Headlines